Literature DB >> 19091326

An immunohistochemical analysis of canine haemangioma and haemangiosarcoma.

S Sabattini1, G Bettini.   

Abstract

The aim of the present study was to investigate immunohistochemically aspects of the biology of canine endothelial neoplasia. Forty samples of canine cutaneous and visceral haemangiosarcoma (HSA), 29 samples of cutaneous and visceral haemangioma (HA) and 10 control samples of granulation tissue (GT) were labelled with antisera specific for vimentin, smooth muscle actin, von Willebrand factor (vWF), CD117 (KIT), vascular endothelial growth factor receptor-3 (VEGFR-3), vascular endothelial growth factor-C (VEGFC) and CD44. Further antisera were employed to determine the level of cellular proliferation (MIB-1 index) and toluidine blue staining was used to detect populations of tumour-infiltrating mast cells (MCs). There was greater expression of CD117, VEGFR-3 and CD44 in HSA than in HA, suggesting that these proteins might be suitable targets for the future development of novel therapeutic approaches to canine HSA. Marked infiltration of MC was detected in HA, suggesting a possible role for these cells in the pathogenesis of benign vascular neoplasia in the dog.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091326     DOI: 10.1016/j.jcpa.2008.10.006

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  13 in total

1.  Magnetic resonance imaging and immunohistochemistry of primary vertebral hemangiosarcoma in a dog and implications for diagnosis and therapy.

Authors:  Claudia Pérez-Martínez; Marta Regueiro-Purriños; Beatriz Fernández-Martínez; José R Altónaga; José M Gonzalo-Orden; María J García-Iglesias
Journal:  Can Vet J       Date:  2016-12       Impact factor: 1.008

2.  Mast cells in canine cutaneous hemangioma, hemangiosarcoma and mammary tumors.

Authors:  Moges Woldemeskel; Sreekumari Rajeev
Journal:  Vet Res Commun       Date:  2010-02-03       Impact factor: 2.459

Review 3.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

4.  Hemangiosarcoma in a geriatric Labrador retriever.

Authors:  Diya Sharma
Journal:  Can Vet J       Date:  2012-08       Impact factor: 1.008

5.  Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma.

Authors:  Vittal Kurisetty; Brad A Bryan
Journal:  Angiol Open Access       Date:  2013-04-08

6.  Ki-67 protein expression and tumor associated inflammatory cells (macrophages and mast cells) in canine colorectal carcinoma.

Authors:  M Woldemeskel; I Hawkins; L Whittington
Journal:  BMC Vet Res       Date:  2017-04-20       Impact factor: 2.741

7.  Primary intrapelvic hemangiosarcoma in a dog.

Authors:  Saejong Yoo; Jiyong Kim; Hyun-Wook Myung; Suhan Woo; Dai-Jung Chung; A-Jin Lee; Han-Jun Kim; Sun-Hee DO; Hwi-Yool Kim
Journal:  J Vet Med Sci       Date:  2016-10-15       Impact factor: 1.267

8.  Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro.

Authors:  Milan Milovancev; Stuart C Helfand; Kevin Marley; Cheri P Goodall; Christiane V Löhr; Shay Bracha
Journal:  BMC Vet Res       Date:  2016-06-04       Impact factor: 2.741

9.  Identification of the two KIT isoforms and their expression status in canine hemangiosarcomas.

Authors:  Yi-Chen Chen; Jiunn-Wang Liao; Wei-Li Hsu; Shih-Chieh Chang
Journal:  BMC Vet Res       Date:  2016-07-16       Impact factor: 2.741

10.  Tumor microvessel density-associated mast cells in canine nodal lymphoma.

Authors:  Moges Woldemeskel; Elizabeth Mann; Lisa Whittington
Journal:  SAGE Open Med       Date:  2014-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.